As an industry pioneer and leader, Theragenics Corporation has an unparalleled history of more than 35 years in the manufacture and global supply and distribution of low-dose rate (LDR) brachytherapy seeds for the treatment of:

  • Prostate cancer
  • Lung cancer
  • Intra-ocular malignancies
  • Benign disease
  • Other solid tumors


Brachytherapy Product Portfolio 

see “BrachyTherapy” menu drop down

  • Diverse range of products to meet your implant needs
  • Backed by Theragenics’ trusted experience and quality
  • Dedicated, experienced team and physics expertise to service and support your implant needs
  • Continues to invest & develop innovative brachytherapy solutions to better serve physicians and their patients